Compare $AIM vs $OSRH | Chartloom

Compare

$AIM vs $OSRH

AIM ImmunoTech Inc · OSR Holdings Inc

AIM

AIM ImmunoTech Inc

OSRH

OSR Holdings Inc

Compare $AIM vs $OSRH

Comparing AIM ImmunoTech Inc and OSR Holdings Inc

AIMAIM ImmunoTech Inc

OSRHOSR Holdings Inc

AIMAIM ImmunoTech Inc

Market cap

$5M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-21.5%

YTD performance

-84.4%

52W performance

-92.8%

FCF yield

-292.9%

OSRHOSR Holdings Inc

Market cap

$7M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

-4.6%

YTD performance

-64.4%

52W performance

-65.3%

FCF yield

-100.0%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

AIM

OSRH

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

OSRH

OSR Holdings Inc

Market Cap

AIM$5M

OSRH$7M

Enterprise Value

AIM$-1M

OSRH$11M

Price

AIM$0.18

OSRH$0.21

P/E Ratio

AIMN/A

OSRHN/A

P/S Ratio

AIM52.52x

OSRH4.08x

EV/Sales

AIM-13.57x

OSRH6.25x

EV/EBITDA

AIM0.00x

OSRH0.00x

P/B Ratio

AIM0.91x

OSRH0.07x

P/FCF Ratio

AIMN/A

OSRHN/A

EV/FCF

AIM0.09x

OSRH-1.53x

PEG Ratio

AIMN/A

OSRHN/A

Forward P/E (NTM)

AIMN/A

OSRHN/A

Forward P/S (NTM)

AIMN/A

OSRHN/A

Revenue (TTM)

AIM$95K

OSRH$2M

Revenue Growth (YoY)

AIM-21.5%

OSRH-4.6%

Forward Rev Growth

AIM-32.4%

OSRH0.0%

Gross Margin (TTM)

AIM-23.2%

OSRH35.3%

Operating Margin (TTM)

AIM0.0%

OSRH0.0%

EBITDA Margin (TTM)

AIM-10985.3%

OSRH-410.1%

Net Margin (TTM)

AIM-15021.1%

OSRH-593.2%

FCF Margin (TTM)

AIM-15385.3%

OSRH-407.9%

Net Income (TTM)

AIM$-14M

OSRH$-11M

FCF (TTM)

AIM$-15M

OSRH$-7M

EPS (TTM)

AIM-$0.83

OSRH-$0.25

ROE (TTM)

AIM-13803.0%

OSRH-1167.0%

ROA (TTM)

AIM-17514.0%

OSRH-624.0%

ROIC (TTM)

AIM-7694.0%

OSRH-1110.0%

Cash

AIM$10M

OSRH$1M

Debt

AIM$4M

OSRH$5M

Net Cash/Debt

AIM$6M

OSRH$-4M

Current Ratio (TTM)

AIM2.11x

OSRH0.18x

Quick Ratio (TTM)

AIM2.01x

OSRH0.14x

Debt/Equity (TTM)

AIM0.47x

OSRH0.05x

Debt/Assets (TTM)

AIM0.0%

OSRH0.0%

Interest Coverage (TTM)

AIMN/A

OSRHN/A

Net Debt/EBITDA (TTM)

AIM0.00x

OSRH0.00x

Beta

AIM1.35

OSRH0.51

52W Performance

AIM-92.8%

OSRH-65.3%

YTD Performance

AIM-84.4%

OSRH-64.4%

% from 52W High

AIM-93.6%

OSRH-76.9%

% from 52W Low

AIM8.4%

OSRH180.0%

Asset Turnover (TTM)

AIM0.01x

OSRH0.01x

FCF Yield (TTM)

AIM-292.9%

OSRH-100.0%

Earnings Yield (TTM)

AIM-286.0%

OSRH-145.5%

Dividend Yield (TTM)

AIMN/A

OSRHN/A

Rule of 40

AIM-15,406.8

OSRH-412.5

EV/GP/RG

AIMN/A

OSRHN/A

Ticker research

View AIM research View OSRH research

Metric	AIM AIM ImmunoTech Inc	OSRH OSR Holdings Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$11M
Price	$0.18	$0.21
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	4.08x
EV/Sales	-13.57x	6.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	0.09x	-1.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$2M
Revenue Growth (YoY)	-21.5%	-4.6%
Forward Rev Growth	-32.4%	0.0%
Profitability
Gross Margin (TTM)	-23.2%	35.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10985.3%	-410.1%
Net Margin (TTM)	-15021.1%	-593.2%
FCF Margin (TTM)	-15385.3%	-407.9%
Net Income (TTM)	$-14M	$-11M
FCF (TTM)	$-15M	$-7M
EPS (TTM)	-$0.83	-$0.25
ROE (TTM)	-13803.0%	-1167.0%
ROA (TTM)	-17514.0%	-624.0%
ROIC (TTM)	-7694.0%	-1110.0%
Financial Health
Cash	$10M	$1M
Debt	$4M	$5M
Net Cash/Debt	$6M	$-4M
Current Ratio (TTM)	2.11x	0.18x
Quick Ratio (TTM)	2.01x	0.14x
Debt/Equity (TTM)	0.47x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	0.51
52W Performance	-92.8%	-65.3%
YTD Performance	-84.4%	-64.4%
% from 52W High	-93.6%	-76.9%
% from 52W Low	8.4%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-292.9%	-100.0%
Earnings Yield (TTM)	-286.0%	-145.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	-412.5
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View OSRH research

Valuation

P/S Ratio

OSRH

4.08x

AIM

52.52x

EV/FCF

OSRH

-1.53x

AIM

0.09x

Growth & revenue

Revenue Growth TTM

OSRH

-4.6%

AIM

-21.5%

Forward Revenue Growth

OSRH

0.0%

AIM

-32.4%

Profitability & performance

Gross Margin

OSRH

35.3%

AIM

-23.2%

ROE

OSRH

-1167.0%

AIM

-13803.0%

FCF Yield %

OSRH

-100.0%

AIM

-292.9%

52-Week Performance

OSRH

-65.3%

AIM

-92.8%

Detailed metrics comparison

AIM

AIM ImmunoTech Inc

OSRH

OSR Holdings Inc

Market Cap

AIM$5M

OSRH$7M

Enterprise Value

AIM$-1M

OSRH$11M

Price

AIM$0.18

OSRH$0.21

P/E Ratio

AIMN/A

OSRHN/A

P/S Ratio

AIM52.52x

OSRH4.08x

EV/Sales

AIM-13.57x

OSRH6.25x

EV/EBITDA

AIM0.00x

OSRH0.00x

P/B Ratio

AIM0.91x

OSRH0.07x

P/FCF Ratio

AIMN/A

OSRHN/A

EV/FCF

AIM0.09x

OSRH-1.53x

PEG Ratio

AIMN/A

OSRHN/A

Forward P/E (NTM)

AIMN/A

OSRHN/A

Forward P/S (NTM)

AIMN/A

OSRHN/A

Revenue (TTM)

AIM$95K

OSRH$2M

Revenue Growth (YoY)

AIM-21.5%

OSRH-4.6%

Forward Rev Growth

AIM-32.4%

OSRH0.0%

Gross Margin (TTM)

AIM-23.2%

OSRH35.3%

Operating Margin (TTM)

AIM0.0%

OSRH0.0%

EBITDA Margin (TTM)

AIM-10985.3%

OSRH-410.1%

Net Margin (TTM)

AIM-15021.1%

OSRH-593.2%

FCF Margin (TTM)

AIM-15385.3%

OSRH-407.9%

Net Income (TTM)

AIM$-14M

OSRH$-11M

FCF (TTM)

AIM$-15M

OSRH$-7M

EPS (TTM)

AIM-$0.83

OSRH-$0.25

ROE (TTM)

AIM-13803.0%

OSRH-1167.0%

ROA (TTM)

AIM-17514.0%

OSRH-624.0%

ROIC (TTM)

AIM-7694.0%

OSRH-1110.0%

Cash

AIM$10M

OSRH$1M

Debt

AIM$4M

OSRH$5M

Net Cash/Debt

AIM$6M

OSRH$-4M

Current Ratio (TTM)

AIM2.11x

OSRH0.18x

Quick Ratio (TTM)

AIM2.01x

OSRH0.14x

Debt/Equity (TTM)

AIM0.47x

OSRH0.05x

Debt/Assets (TTM)

AIM0.0%

OSRH0.0%

Interest Coverage (TTM)

AIMN/A

OSRHN/A

Net Debt/EBITDA (TTM)

AIM0.00x

OSRH0.00x

Beta

AIM1.35

OSRH0.51

52W Performance

AIM-92.8%

OSRH-65.3%

YTD Performance

AIM-84.4%

OSRH-64.4%

% from 52W High

AIM-93.6%

OSRH-76.9%

% from 52W Low

AIM8.4%

OSRH180.0%

Asset Turnover (TTM)

AIM0.01x

OSRH0.01x

FCF Yield (TTM)

AIM-292.9%

OSRH-100.0%

Earnings Yield (TTM)

AIM-286.0%

OSRH-145.5%

Dividend Yield (TTM)

AIMN/A

OSRHN/A

Rule of 40

AIM-15,406.8

OSRH-412.5

EV/GP/RG

AIMN/A

OSRHN/A

Ticker research

View AIM research View OSRH research

Metric	AIM AIM ImmunoTech Inc	OSRH OSR Holdings Inc
Market & Valuation
Market Cap	$5M	$7M
Enterprise Value	$-1M	$11M
Price	$0.18	$0.21
P/E Ratio	N/A	N/A
P/S Ratio	52.52x	4.08x
EV/Sales	-13.57x	6.25x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.91x	0.07x
P/FCF Ratio	N/A	N/A
EV/FCF	0.09x	-1.53x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$95K	$2M
Revenue Growth (YoY)	-21.5%	-4.6%
Forward Rev Growth	-32.4%	0.0%
Profitability
Gross Margin (TTM)	-23.2%	35.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-10985.3%	-410.1%
Net Margin (TTM)	-15021.1%	-593.2%
FCF Margin (TTM)	-15385.3%	-407.9%
Net Income (TTM)	$-14M	$-11M
FCF (TTM)	$-15M	$-7M
EPS (TTM)	-$0.83	-$0.25
ROE (TTM)	-13803.0%	-1167.0%
ROA (TTM)	-17514.0%	-624.0%
ROIC (TTM)	-7694.0%	-1110.0%
Financial Health
Cash	$10M	$1M
Debt	$4M	$5M
Net Cash/Debt	$6M	$-4M
Current Ratio (TTM)	2.11x	0.18x
Quick Ratio (TTM)	2.01x	0.14x
Debt/Equity (TTM)	0.47x	0.05x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.35	0.51
52W Performance	-92.8%	-65.3%
YTD Performance	-84.4%	-64.4%
% from 52W High	-93.6%	-76.9%
% from 52W Low	8.4%	180.0%
Efficiency & Yields
Asset Turnover (TTM)	0.01x	0.01x
FCF Yield (TTM)	-292.9%	-100.0%
Earnings Yield (TTM)	-286.0%	-145.5%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-15,406.8	-412.5
EV/GP/RG	N/A	N/A
Ticker research	View AIM research	View OSRH research